The ambiguity in immunology

Frontiers in Immunology

Volumn 3, Issue FEB, 2012, Pages

  Barnaba, Vincenzo ^a   Paroli, Marino ^a   Piconese, Silvia ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ambiguity; Autoimmunity; Cancer; Homeostasis; Inflammation

Indexed keywords

EID: 84874125714     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00018     Document Type: Review

References (216)

1. Accapezzato, D., Francavilla, V., Paroli, M., Casciaro, M., Chircu, L. V., Civi-dini, A., Abrignani, S., Mondelli, M. U., and Barnaba, V. (2004). Hepatic expansion of a virus-specific regu-latory CD8(+) T cell population in chronic hepatitis C virus infection. J. Clin. Invest. 113, 963-972.
2. Accapezzato, D., Visco, V., Francav-illa, V., Molette, C., Donato, T., Paroli, M., Mondelli, M. U., Doria, M., Torrisi, M. R., and Barnaba, V. (2005). Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo. J. Exp. Med. 202, 817-828.
3. Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., and Sallusto, F. (2007). Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942-949.
4. Agrawal, A., Eastman, Q. M., and Schatz, D. G. (1998). Transposition medi-ated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394, 744-751.
5. Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801.
6. Alard, J. E., Dueymes, M., Youinou, P., and Jamin, C. (2008). HSP60 and anti-HSP60 antibodies in vasculitis: they are two of a kind. Clin. Rev. Allergy Immunol. 35, 66-71.
7. Albert, M. L. (2004). Death-defying immunity: do apoptotic cells influ-ence antigen processing and pre-sentation? Nat. Rev. Immunol. 4, 223-231.
8. Anderson, M. S., Venanzi, E. S., Klein, L., Chen, Z., Berzins, S. P., Turley, S. J., von Boehmer, H., Bronson, R., Dierich, A., Benoist, C., and Mathis, D. (2002). Projection of an immunological self shadow within the thymus by the aire protein. Sci-ence 298, 1395-1401.
9. Avrameas, S. (1991). Natural autoanti-bodies: from 'horror autotoxicus to 'gnothi seauton Immunol. Today 12, 154-159.
10. Bachem, A., Guttler, S., Hartung, E., Ebstein, F., Schaefer, M., Tannert, A., Salama, A., Movassaghi, K., Opitz, C., Mages, H. W., Henn, V., Kloet-zel, P. M., Gurka, S., and Kroczek, R. A. (2010). Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J. Exp. Med. 207, 1273-1281.
11. Bangs, S. C., McMichael, A. J., and Xu, X. N. (2006). Bystander T cell activa-tion -implications for HIV infection and other diseases. Trends Immunol. 27, 518-524.
12. Barber, D. L., Wherry, E. J., Maso-pust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., and Ahmed, R. (2006). Restoring func-tion in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687.
13. Barnaba, V. (1996). Viruses, hid-den self-epitopes and autoimmu-nity. Immunol. Rev. 152, 47-66.
14. Barron, L., Knoechel, B., Lohr, J., and Abbas, A. K. (2008). Cutting edge: contributions of apoptosis and anergy to systemic T cell tolerance. J. Immunol. 180, 2762-2766.
15. Barthlott, T., Kassiotis, G., and Stockinger, B. (2003). T cell regula-tion as a side effect of homeostasis and competition. J. Exp. Med. 197, 451-460.
16. Barthlott, T., Moncrieffe, H., Veldhoen, M., Atkins, C. J., Christensen, J., O'Garra, A., and Stockinger, B. (2005). CD25+ CD4+ Tcells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. Int. Immunol. 17, 279-288.
17. Belkaid, Y. (2007). Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7, 875-888.
18. Benoist, C., and Mathis, D. (2001). Autoimmunity provoked by infec-tion: how good is the case for T cell epitope mimicry? Nat. Immunol. 2, 797-801.
19. Bettelli, E., Korn, T., and Kuchroo, V. K. (2007). Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol. 19, 652-657.
20. Blachere, N. E., Darnell, R. B., and Albert, M. L. (2005). Apoptotic cells deliver processed antigen to den-dritic cells for cross-presentation. PLoS Biol. 3, e185. doi:10.1371/jour-nal.pbio.0030185.
21. Bleger, J. (1967). Simbiosis y ambiguedad, estudio psiconalitico. Buenos Aires: Editorial Paidos.
22. Bluestone, J. A., and Abbas, A. K. (2003). Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3, 253-257.
23. Borgulya, P., Kishi, H., Uematsu, Y., and von Boehmer, H. (1992). Exclusion and inclusion of alpha and beta T cell receptor alleles. Cell 69, 529-537.
24. Burgdorf, S., Kautz, A., Bohnert, V., Knolle, P. A., and Kurts, C. (2007). Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316, 612-616.
25. Cao, W., Rosen, D. B., Ito, T., Bover, L., Bao, M., Watanabe, G., Yao, Z., Zhang, L., Lanier, L. L., and Liu, Y. J. (2006). Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits toll-like receptor-induced interferon production. J. Exp. Med. 203, 1399-1405.
26. Casanova, J. L., Romero, P., Widmann, C., Kourilsky, P., and Maryanski, J. L. (1991). T cell receptor genes in a series of class I major histocompat-ibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclu-sion and antigen-specific repertoire. J. Exp. Med. 174, 1371-1383.
27. Chatenoud, L., Salomon, B., and Blue-stone, J. A. (2001). Suppressor T cells -theyre back and critical for regulation of autoimmunity! Immunol. Rev. 182, 149-163.
28. Chen, W., Frank, M. E., Jin, W., and Wahl, S. M. (2001). TGF-beta released by apoptotic T cells con-tributes to an immunosuppressive milieu. Immunity 14, 715-725.
29. Chernysheva, A. D., Kirou, K. A., and Crow, M. K. (2002). T cell prolifer-ation induced by autologous non-T cells is a response to apoptotic cells processed by dendritic cells. J. Immunol. 169, 1241-1250.
30. Cho, J. H. (2008). The genetics and immunopathogenesis of inflam-matory bowel disease. Nat. Rev. Immunol. 8, 458-466.
31. Coffer, P. J., and Burgering, B. M. (2004). Forkhead-box transcription factors and their role in the immune system. Nat. Rev. Immunol. 4, 889-899.
32. Colombo, M. P., and Piconese, S. (2007). Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy. Nat. Rev. Cancer 7, 880-887.
33. Coombes, J. L., and Powrie, F. (2008). Dendritic cells in intestinal immune regulation. Nat. Rev. Immunol. 8, 435-446.
34. Coombes, J. L., Robinson, N. J., Maloy, K. J., Uhlig, H. H., and Powrie, F. (2005). Regulatory T cells and intestinal homeostasis. Immunol. Rev. 204, 184-194.
35. Crozat, K., Guiton, R., Contreras, V., Feuillet, V., Dutertre, C. A., Ventre, E., Vu Manh, T. P., Baranek, T., Storset, A. K., Marvel, J., Boudinot, P., Hosmalin, A., Schwartz-Cornil, I., and Dalod, M. (2010). The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J. Exp. Med. 207, 1283-1292.
36. Curiel, T. J. (2007). Tregs and rethink-ing cancer immunotherapy. J. Clin. Invest. 117, 1167-1174.
37. Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M. L., Knutson, K. L., Chen, L., and Zou, W. (2004). Specific recruitment of regulatory T cells in ovarian carci-noma fosters immune privilege and predicts reduced survival. Nat. Med. 10, 942-949.
38. Curtis, M. M., and Way, S. S. (2009). Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126, 177-185.
39. Cvetanovich, G. L., and Hafler, D. A. (2010). Human regulatory T cells in autoimmune diseases. Curr. Opin. Immunol. 22, 753-760.
40. Dash, P., McClaren, J. L., Oguin, T. H. III, Rothwell, W., Todd, B., Morris, M. Y., Becksfort, J., Reynolds, C., Brown, S. A., Doherty, P. C., and Thomas, P. G. (2010). Paired analysis of TCRalpha and TCRbeta chains at the single-cell level in mice. J. Clin. Invest. 121, 288-295.
41. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., Mncube, Z., Duraiswamy, J., Zhu, B., Eich-baum, Q., Altfeld, M., Wherry, E. J., Coovadia, H. M., Goulder, P. J., Klen-erman, P., Ahmed, R., Freeman, G. J., and Walker, B. D. (2006). PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350-354.
42. de Jong, E. C., Smits, H. H., and Kapsenberg, M. L. (2005). Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26, 289-307.
43. de la Rosa, M., Rutz, S., Dorninger, H., and Scheffold, A. (2004). Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2480-2488.
44. De Vita, L., Accapezzato, D., Mangino, G., Morrone, S., Santilio, I., Cas-ciaro, M. A., Fava, D., Bruno, G., Del Prete, G., Santoni, A., and Barnaba, V. (1998). Defective Th1 and Th2 cytokine synthesis in the T-T cell presentation model for lack of CD40/CD40 ligand interaction. Eur. J. Immunol. 28, 3552-3563.
45. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F., Enjyoji, K., Linden, J., Oukka, M., Kuchroo, V. K., Strom, T. B., and Robson, S. C. (2007). Adeno-sine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265.
46. Di Pucchio, T., Chatterjee, B., Smed-Sorensen, A., Clayton, S., Palazzo, A., Montes, M., Xue, Y., Mellman, I., Banchereau, J., and Connolly, J. E. (2008). Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid den-dritic cells on major histocompati-bility complex class I. Nat. Immunol. 9, 551-557.
47. Di Rosa, F., and Barnaba, V. (1998). Per-sisting viruses and chronic inflam-mation:understanding their relation to autoimmunity. Immunol. Rev. 164, 17-27.
48. Dominguez-Villar, M., Baecher-Allan, C. M., and Hafler, D.A. (2011). Iden-tification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat. Med. 17, 673-675.
49. Dong, C. (2008). TH17 cells in devel-opment: an updated view of their molecular identity and genetic pro-gramming. Nat. Rev. Immunol. 8, 337-348.
50. Dudziak, D., Kamphorst, A. O., Hei-dkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H. W., Park, C. G., Steinman, R. M., and Nussen-zweig, M. C. (2007). Differential antigen processing by dendritic cell subsets in vivo. Science 315,107-111.
51. Duhen, T., Geiger, R., Jarrossay, D., Lan-zavecchia, A., and Sallusto, F. (2009). Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10, 857-863.
52. Ebinuma, H., Nakamoto, N., Li, Y., Price, D. A., Gostick, E., Levine, B. L., Tobias, J., Kwok, W. W., and Chang, K. M. (2008). Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. J. Virol. 82, 5043-5053.
53. Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., and Mauri, C. (2004). Compro-mised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 200, 277-285.
54. Elliott, J. I., and Altmann, D. M. (1995). Dual T cell receptor alpha chain T cells in autoimmunity. J. Exp. Med. 182, 953-959.
55. Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., Cianfarani, F., Odorisio, T., Traidl-Hoffmann, C., Behrendt, H., Durham, S. R., Schmidt-Weber, C. B., and Cavani, A. (2009). Th22 cells represent a distinct human T cell subset involved in epidermal immu-nity and remodeling. J. Clin. Invest. 119, 3573-3585.
56. Ferguson, T. A., Green, D. R., and Griffith, T. S. (2002). Cell death and immune privilege. Int. Rev. Immunol. 21, 153-172.
57. Fontenot, J. D., Gavin, M. A., and Rudensky, A. Y. (2003). Foxp3 pro-grams the development and func-tion of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336.
58. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., and Rudensky, A. Y. (2005). A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151.
59. Franceschini, D., Paroli, M., Francav-illa, V., Videtta, M., Morrone, S., Labbadia, G., Cerino, A., Mon-delli, M. U., and Barnaba, V. (2009). PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by lim-iting STAT-5 phosphorylation in patients chronically infected with HCV. J. Clin. Invest. 119, 551-564.
60. Fritz, J. H., Ferrero, R. L., Philpott, D. J., and Girardin, S. E. (2006). Nod-like proteins in immunity, inflam-mation and disease. Nat. Immunol. 7, 1250-1257.
61. Gallucci, S., and Matzinger, P. (2001). Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13, 114-119.
62. Gao, Y., Herndon, J. M., Zhang, H., Grif-fith, T. S., and Ferguson, T. A. (1998). Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188, 887-896.
63. Gardner, J. M., Devoss, J. J., Fried-man, R. S., Wong, D. J., Tan, Y. X., Zhou, X., Johannes, K. P., Su, M. A., Chang, H. Y., Krummel, M. F., and Anderson, M. S. (2008). Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 321, 843-847.
64. Gillard, G. O., Dooley, J., Erickson, M., Peltonen, L., and Farr, A. G. (2007). Aire-dependent alter-ations in medullary thymic epithe-lium indicate a role for Aire in thymic epithelial differentiation. J. Immunol. 178, 3007-3015.
65. Griffith, T. S., Kazama, H., VanOosten, R. L., Earle, J. K. Jr., Herndon, J. M., Green, D. R., and Fergu-son, T. A. (2007). Apoptotic cells induce tolerance by generating help-less CD8+ T cells that produce TRAIL. J. Immunol. 178, 2679-2687.
66. Grossman, Z., Meier-Schellersheim, M., Paul, W. E., and Picker, L. J. (2006). Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 12, 289-295.
67. Guermonprez, P., Saveanu, L., Klei-jmeer, M., Davoust, J., Van Endert, P., and Amigorena, S. (2003). ER-phagosome fusion defines an MHC class I cross-presentation compart-ment in dendritic cells. Nature 425, 397-402.
68. Guiducci, C., Ott, G., Chan, J. H., Damon, E., Calacsan, C., Matray, T., Lee, K. D., Coffman, R. L., and Bar-rat, F. J. (2006). Properties regulating the nature of the plasmacytoid den-dritic cell response to toll-like recep-tor 9 activation. J. Exp. Med. 203, 1999-2008.
69. Hardy, R. R., and Hayakawa, K. (2001). B cell development pathways. Annu. Rev. Immunol. 19, 595-621.
70. He, X., Janeway, C. A. Jr., Levine, M., Robinson, E., Preston-Hurlburt, P., Viret, C., and Bottomly, K. (2002). Dual receptor T cells extend the immune repertoire for for-eign antigens. Nat. Immunol. 3, 127-134.
71. Heeg, M. H., Ulsenheimer, A., Gruner, N. H., Zachoval, R., Jung, M. C., Ger-lach, J. T., Raziorrouh, B., Schraut, W., Horster, S., Kauke, T., Spannagl, M., and Diepolder, H. M. (2009). FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C. Gastroenterology 137, 1280-1288. e1281-e1286.
72. Hintikka, J. (1959). Aristotle and the ambiguity of ambiguity. Inquiry 2, 137-151.
73. Hoebe, K., Janssen, E., and Beutler, B. (2004). The interface between innate and adaptive immunity. Nat. Immunol. 5, 971-974.
74. Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development by the tran-scription factor Foxp3. Science 299, 1057-1061.
75. Hsieh, C. S., Liang, Y., Tyznik, A. J., Self, S. G., Liggitt, D., and Ruden-sky, A. Y. (2004). Recognition of the peripheral self by naturally arisingCD25+ CD4+ T cell receptors. Immunity 21, 267-277.
76. Huehn, J., Polansky, J. K., and Hamann, A. (2009). Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat. Rev. Immunol. 9, 83-89.
77. Inaba, K., Turley, S., Yamaide, F., Iyoda, T., Mahnke, K., Inaba, M., Pack, M., Subklewe, M., Sauter, B., Sheff, D., Albert, M., Bhardwaj, N., Mellman, I., and Steinman, R. M. (1998). Effi-cient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188, 2163-2173.
78. Inohara, N., Chamaillard, M., McDon-ald, C., and Nunez, G. (2005). NOD-LRR proteins: role in host-microbial interactions and inflam-matory disease. Annu. Rev. Biochem. 74, 355-383.
79. Jakobson, R. (1995). "On realism in art," in On Language, Chap. I, eds. L. Waugh and M. Monville-Burston (Cambridge: Harvard Uni-versity Press), 21-23.
80. Jameson, S. C., and Bevan, M. J. (1998). T-cell selection. Curr. Opin. Immunol. 10, 214-219.
81. Janeway, C. A. Jr., and Medzhitov, R. (2002). Innate immune recognition. Annu. Rev. Immunol. 20, 197-216.
82. Jego, G., Palucka, A. K., Blanck, J. P., Chalouni, C., Pascual, V., and Banchereau, J. (2003). Plasmacytoid dendritic cells induce plasma cell differentiation through type I inter-feron and interleukin 6. Immunity 19, 225-234.
83. Ji, Q., Perchellet, A., and Goverman, J. M. (2010). Viral infection trig-gers central nervous system autoim-munity via activation of CD8+ T cells expressing dual TCRs. Nat. Immunol. 11, 628-634.
84. Jiang, A., Bloom, O., Ono, S., Cui, W., Unternaehrer, J., Jiang, S., Whitney, J. A., Connolly, J., Banchereau, J., and Mellman, I. (2007). Disrup-tion of E-cadherin-mediated adhe-sion induces a functionally distinct pathway of dendritic cell matura-tion. Immunity 27, 610-624.
85. Kawai, T., and Akira, S. (2006). Innate immune recognition of viral infec-tion. Nat. Immunol. 7, 131-137.
86. Kazama, H., Ricci, J. E., Herndon, J. M., Hoppe, G., Green, D. R., and Ferguson, T. A. (2008). Induction of immunological tol-erance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29, 21-32.
87. Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M., Freeman, G. J., Sayegh, M. H., and Sharpe, A. H. (2006). Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203, 883-895.
88. Killeen, N., Irving, B. A., Pippig, S., and Zingler, K. (1998). Signaling checkpoints during the development of T lymphocytes. Curr. Opin. Immunol. 10, 360-367.
89. Klareskog, L., Widhe, M., Hermans-son, M., and Ronnelid, J. (2008). Antibodies to citrullinated proteins in arthritis: pathology and promise. Curr. Opin. Rheumatol. 20, 300-305.
90. Klechevsky, E., Liu, M., Morita, R., Banchereau, R., Thompson-Snipes, L., Palucka, A. K., Ueno, H., and Banchereau, J. (2009). Understand-ing human myeloid dendritic cell subsets for the rational design of novel vaccines. Hum. Immunol. 70, 281-288.
91. Klechevsky, E., Morita, R., Liu, M., Cao, Y., Coquery, S., Thompson-Snipes, L., Briere, F., Chaussabel, D., Zurawski, G., Palucka, A. K., Reiter, Y., Banchereau, J., and Ueno, H. (2008). Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29, 497-510.
92. Klenerman, P., and Hill, A. (2005). T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 6, 873-879.
93. Korn, T., Bettelli, E., Oukka, M., and Kuchroo, V. K. (2009). IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517.
94. Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C., and von Boehmer, H. (2005). Induc-ing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219-1227.
95. Kuroda, N., Mitani, T., Takeda, N., Ishi-maru, N., Arakaki, R., Hayashi, Y., Bando, Y., Izumi, K., Takahashi, T., Nomura, T., Sakaguchi, S., Ueno, T., Takahama, Y., Uchida, D., Sun, S., Kajiura, F., Mouri, Y., Han, H., Mat-sushima, A., Yamada, G., and Mat-sumoto, M. (2005). Development of autoimmunity against transcrip-tionally unrepressed target antigen in the thymus of Aire-deficient mice. J. Immunol. 174, 1862-1870.
96. Kurts, C., Heath, W. R., Kosaka, H., Miller, J. F., and Carbone, F. R. (1998). The peripheral dele-tion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J. Exp. Med. 188, 415-420.
97. Lal, G., and Bromberg, J. S. (2009). Epi-genetic mechanisms of regulation of Foxp3 expression. Blood 114, 3727-3735.
98. Landau, D. A., Saadoun, D., Calabrese, L. H., and Cacoub, P. (2007). The pathophysiology of HCV induced B-cell clonal disorders. Autoimmun. Rev. 6, 581-587.
99. Lang, K. S., Recher, M., Junt, T., Navarini, A. A., Harris, N. L., Freigang, S., Odermatt, B., Conrad, C., Ittner, L. M., Bauer, S., Luther, S. A., Uematsu, S., Akira, S., Hen-gartner, H., and Zinkernagel, R. M. (2005). Toll-like receptor engage-ment converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 11, 138-145.
100. Lanzavecchia, A., and Sallusto, F. (2001). Regulation of T cell immunity by dendritic cells. Cell 106, 263-266.
101. Lanzavecchia, A., and Sallusto, F. (2007). Toll-like receptors and innate immunity in B-cell activation and antibody responses. Curr. Opin. Immunol. 19, 268-274.
102. Lerman, M. A., Larkin, J. III, Cozzo, C., Jordan, M. S., and Caton, A. J. (2004). CD4+ CD25+ regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen. J. Immunol. 173, 236-244.
103. Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M., and Tree, T. I. (2005). Defective suppressor function in CD4(+)CD25(+)T-cells from patients with type 1 dia-betes. Diabetes 54, 92-99.
104. Liston, A., Lesage, S., Wilson, J., Pelto-nen, L., and Goodnow, C. C. (2003). Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4, 350-354.
105. Luger, D., Silver, P. B., Tang, J., Cua, D., Chen, Z., Iwakura, Y., Bowman, E. P., Sgambellone, N. M., Chan, C. C., and Caspi, R. R. (2008). Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 205, 799-810.
106. Lund, J. M., Hsing, L., Pham, T. T., and Rudensky, A. Y. (2008). Coordina-tion of early protective immunity to viral infection by regulatory T cells. Science 320, 1220-1224.
107. Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. (2008a). Cancer-related inflammation. Nature 454, 436-444.
108. Mantovani, A., Romero, P., Palucka, A. K., and Marincola, F. M. (2008b). Tumour immunity: effec-tor response to tumour and role of the microenvironment. Lancet 371, 771-783.
109. Marrack, P., McCormack, J., and Kappler, J. (1989). Presentation of antigen, foreign major histocompat-ibility complex proteins and self by thymus cortical epithelium. Nature 338, 503-505.
110. Marshak-Rothstein, A. (2006). Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6, 823-835.
111. Masopust, D., and Ahmed, R. (2004). Reflections on CD8 T-cell activa-tion and memory. Immunol. Res. 29, 151-160.
112. Matsui, T., Connolly, J. E., Michnevitz, M., Chaussabel, D., Yu, C. I., Glaser, C., Tindle, S., Pypaert, M., Fre-itas, H., Piqueras, B., Banchereau, J., and Palucka, A. K. (2009). CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions. J. Immunol. 182, 6815-6823.
113. Matsunaga, T., and Rahman, A. (2001). In search of the origin of the thymus: the thymus and GALT may be evolu-tionarily related. Scand. J. Immunol. 53, 1-6.
114. Matzinger, P. (1994). Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045.
115. Matzinger, P. (2002). An innate sense of danger. Ann. N. Y. Acad. Sci. 961, 341-342.
116. Matzinger, P. (2007). Friendly and dan-gerous signals: is the tissue in con-trol? Nat. Immunol. 8, 11-13.
117. Matzinger, P., and Kamala, T. (2011). Tissue-based class control: the other side of tolerance. Nat. Rev. Immunol. 11, 221-230.
118. McCaughtry, T. M., Baldwin, T. A., Wilken, M. S., and Hogquist, K. A. (2008). Clonal deletion of thymo-cytes can occur in the cortex with no involvement of the medulla. J. Exp. Med. 205, 2575-2584.
119. McGargill, M. A., Derbinski, J. M., and Hogquist, K. A. (2000). Receptor editing in developing T cells. Nat. Immunol. 1, 336-341.
120. McGeachy, M. J., and Cua, D. J. (2008). Th17 cell differentiation: the long and winding road. Immunity 28, 445-453.
121. Medoff, B. D., Thomas, S. Y., and Lus-ter, A. D. (2008). T cell trafficking in allergic asthma: the ins and outs. Annu. Rev. Immunol. 26, 205-232.
122. Medzhitov, R. (2010). Inflammation 2010: new adventures of an old flame. Cell 140, 771-776.
123. Medzhitov, R., and Janeway, C. A. Jr. (2002). Decoding the patterns of self and nonself by the innate immune system. Science 296, 298-300.
124. Meylan, E., Tschopp, J., and Karin, M. (2006). Intracellular pattern recognition receptors in the host response. Nature 442, 39-44.
125. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J., Zajac, A. J., Miller, J. D., Slansky, J., and Ahmed, R. (1998). Count-ing antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177-187.
126. Murphy, K., Travers, P., and Walport, M. (2007). Janeways Immunobiol-ogy, 7th Edn. New York: Garland Science.
127. Nair, S., Boczkowski, D., Fassnacht, M., Pisetsky, D., and Gilboa, E. (2007). Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. Cancer Res. 67, 371-380.
128. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., and Paul, W. E. (1999). The IL-4 receptor: signaling mecha-nisms and biologic functions. Annu. Rev. Immunol. 17, 701-738.
129. Neuberger, M. S. (1997). Antigen recep-tor signaling gives lymphocytes a long life. Cell 90, 971-973.
130. Nikolich-Zugich, J. (2008). Ageing and life-long maintenance of T-cell sub-sets in the face of latent persistent infections. Nat. Rev. Immunol. 8, 512-522.
131. Norbury, C. C., Basta, S., Donohue, K. B., Tscharke, D. C., Princiotta, M. F., Berglund, P., Gibbs, J., Bennink, J. R., and Yewdell, J. W. (2004). CD8+ T cell cross-priming via transfer of proteasome substrates. Science 304, 1318-1321.
132. Oates, J. C., and Gilkeson, G. S. (2002). Mediators of injury in lupus nephritis. Curr. Opin. Rheumatol. 14, 498-503.
133. Oettinger, M. A., Schatz, D. G., Gorka, C., and Baltimore, D. (1990). RAG-1 and RAG-2, adjacent genes that synergistically activateV(D)J recom-bination. Science 248, 1517-1523.
134. Otsuki, T., Maeda, M., Murakami, S., Hayashi, H., Miura, Y., Kusaka, M., Nakano, T., Fukuoka, K., Kishi-moto, T., Hyodoh, F., Ueki, A., and Nishimura, Y. (2007). Immunologi-cal effects of silica and asbestos. Cell. Mol. Immunol. 4, 261-268.
135. Padovan, E., Casorati, G., Dellabona, P., Meyer, S., Brockhaus, M., and Lan-zavecchia, A. (1993). Expression of two T cell receptor alpha chains: dual receptor T cells. Science 262, 422-424.
136. Palucka, K., Banchereau, J., and Mell-man, I. (2010). Designing vaccines based on biology of human dendritic cell subsets. Immunity 33, 464-478.
137. Pandiyan, P., Zheng, L., Ishihara, S., Reed, J., and Lenardo, M. J. (2007). CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8, 1353-1362.
138. Pasqualotto, G. (1997). Illuminismo e illuminazione. Rome: Donzelli.
139. Petrilli, V., Dostert, C., Muruve, D. A., and Tschopp, J. (2007). The inflammasome: a danger sensing complex triggering innate immu-nity. Curr. Opin. Immunol. 19, 615-622.
140. Phillips, R. E. (2002). Immunology taught by Darwin. Nat. Immunol. 3, 987-989.
141. Piconese, S., Pittoni, P., Burocchi, A., Gorzanelli, A., Care, A., Tripodo, C., and Colombo, M. P. (2010). A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2. Eur. J. Immunol. 40, 2902-2913.
142. Piconese, S., Valzasina, B., and Colombo, M. P. (2008). OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. J. Exp. Med. 205, 825-839.
143. Pillai, S. (1999). The chosen few? Posi-tive selection and the generation of naive B lymphocytes. Immunity 10, 493-502.
144. Pope, R. M., and Tschopp, J. (2007). The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthritis Rheum. 56, 3183-3188.
145. Probst, H. C., McCoy, K., Okazaki, T., Honjo, T., and van den Broek, M. (2005). Resting dendritic cells induce peripheral CD8+ T cell tol-erance through PD-1 and CTLA-4. Nat. Immunol. 6, 280-286.
146. Propato, A., Cutrona, G., Francavilla, V., Ulivi, M., Schiaffella, E., Landt, O., Dunbar, R., Cerundolo, V., Fer-rarini, M., and Barnaba, V. (2001). Apoptotic cells overexpress vinculin and induce vinculin-specific cyto-toxic T-cell cross-priming. Nat. Med. 7, 807-813.
147. Pullen, A. M., Kappler, J. W., and Mar-rack, P. (1989). Tolerance to self antigens shapes the T-cell repertoire. Immunol. Rev. 107, 125-139.
148. Rawson, P. M., Molette, C., Videtta, M., Altieri, L., Franceschini, D., Donato, T., Finocchi, L., Propato, A., Paroli, M., Meloni, F., Mas-troianni, C. M., dEttorre, G., Sid-ney, J., Sette, A., and Barnaba, V. (2007). Cross-presentation of caspase-cleaved apoptotic self anti-gens in HIV infection. Nat. Med. 13, 1431-1439.
149. Rice, J. S., Kowal, C., Volpe, B. T., DeGiorgio, L. A., and Diamond, B. (2005). Molecular mimicry: anti-DNA antibodies bind microbial and nonnucleic acid self-antigens. Curr. Top. Microbiol. Immunol. 296, 137-151.
150. Ridge, J. P., Di Rosa, F., and Matzinger, P. (1998). A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393, 474-478.
151. Romagnani, S. (1997). The Th1/Th2 paradigm. Immunol. Today 18, 263-266.
152. Roncarolo, M. G., Levings, M. K., and Traversari, C. (2001). Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 193, F5-F9.
153. Rose, N. R., and Mackay, I. R. (2000). Molecular mimicry: a critical look at exemplary instances in human dis-eases. Cell. Mol. LifeSci.57, 542-551.
154. Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., and Rudensky, A. Y. (2010). Sta-bility of the regulatory T cell lineage in vivo. Science 329, 1667-1671.
155. Ruby, C. E., Yates, M. A., Hirschhorn-Cymerman, D., Chlebeck, P., Wol-chok, J. D., Houghton, A. N., Offner, H., and Weinberg, A. D. (2009). Cut-ting edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right. J. Immunol. 183, 4853-4857.
156. Sabbagh, L., Snell, L. M., and Watts, T. H. (2007). TNF family ligands define niches for T cell memory. Trends Immunol. 28, 333-339.
157. Sagaert, X., De Wolf-Peeters, C., Noels, H., and Baens, M. (2007). The pathogenesis of MALT lymphomas: where do we stand? Leukemia 21, 389-396.
158. Sakaguchi, S. (2004). Naturally aris-ing CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562.
159. Sakaguchi, S. (2005). Naturally aris-ing Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352.
160. Sakaguchi, S., Miyara, M., Costantino, C. M., and Hafler, D. A. (2010). FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10, 490-500.
161. Salemi, S., Caporossi, A. P., Boffa, L., Longobardi, M. G., and Barnaba, V. (1995). HIVgp120 activates autore-active CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing. J. Exp. Med. 181, 2253-2257.
162. Sallusto, F., Geginat, J., and Lanza-vecchia, A. (2004). Central mem-ory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22, 745-763.
163. Sanjabi, S., Zenewicz, L. A., Kamanaka, M., and Flavell, R. A. (2009). Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr. Opin. Pharmacol. 9, 447-453.
164. Savina, A., Jancic, C., Hugues, S., Guer-monprez, P., Vargas, P., Moura, I. C., Lennon-Dumenil, A. M., Seabra, M. C., Raposo, G., and Amigorena, S. (2006). NOX2 controls phago-somal pH to regulate antigen pro-cessing during crosspresentation by dendritic cells. Cell 126, 205-218.
165. Scheffold, A., Huhn, J., and Hofer, T. (2005). Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL-) two to tango. Eur. J. Immunol. 35, 1336-1341.
166. Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F., and Ziegler, S. F. (2001). Scurfin (FOXP3) acts as a repres-sor of transcription and regulates T cell activation. J. Biol. Chem. 276, 37672-37679.
167. Schulz, O., Diebold, S. S., Chen, M., Naslund, T. I., Nolte, M. A., Alex-opoulou, L., Azuma, Y. T., Flavell, R. A., Liljestrom, P., and Reis e Sousa, C. (2005). Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433, 887-892.
168. Serhan, C. N., and Savill, J. (2005). Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191-1197.
169. Setoguchi, R., Hori, S., Takahashi, T., and Sakaguchi, S. (2005). Home-ostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regu-latory T cells by interleukin (IL)-2 and induction of autoimmune dis-ease by IL-2 neutralization. J. Exp. Med. 201, 723-735.
170. Sharma, M. D., Hou, D. Y., Baban, B., Koni, P. A., He, Y., Chandler, P. R., Blazar, B. R., Mellor, A. L., and Munn, D. H. (2010). Reprogrammed foxp3(+) regulatory T cells pro-vide essential help to support cross-presentation and CD8(+)Tcell priming in naive mice. Immunity 33, 942-954.
171. Sharpe, A. H., Wherry, E. J., Ahmed, R., and Freeman, G. J. (2007). The func-tion of programmed cell death 1 and its ligands in regulating autoimmu-nity and infection. Nat. Immunol. 8, 239-245.
172. Shevach, E. M. (2002). CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2, 389-400.
173. Shevach, E. M., McHugh, R. S., Pic-cirillo, C. A., and Thornton, A. M (2001). Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol. Rev. 182, 58-67.
174. Shinkai, Y., Rathbun, G., Lam, K. P., Oltz, E. M., Stewart, V., Mendelsohn, M., Charron, J., Datta, M., Young, F., Stall, A. M., and Alt, F. W. (1992). RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855-867.
175. Shortman, K., and Heath, W. R. (2010). The CD8+ dendritic cell subset. Immunol. Rev. 234, 18-31.
176. Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., and Liu, Y. J. (1999). The nature of the prin-cipal type 1 interferon-producing cells in human blood. Science 284, 1835-1837.
177. Snodgrass, H. R., Kisielow, P., Kiefer, M., Steinmetz, M., and von Boehmer, H. (1985). Ontogeny of the T-cell antigen receptor within the thymus. Nature 313, 592-595.
178. Sprent, J., and Surh, C. D. (2002). T cell memory. Annu. Rev. Immunol. 20, 551-579.
179. Steinman, R. M., Hawiger, D., and Nussenzweig, M. C. (2003). Tolero-genic dendritic cells. Annu. Rev. Immunol. 21, 685-711.
180. Suarez, F., Lortholary, O., Hermine, O., and Lecuit, M. (2006). Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoprolifera-tion. Blood 107, 3034-3044.
181. Surh, C. D., Boyman, O., Purton, J. F., and Sprent, J. (2006). Homeostasis of memory T cells. Immunol. Rev. 211, 154-163.
182. Tan, A., Yeh, S. H., Liu, C. J., Cheung, C., and Chen, P. J. (2008). Viral hepa-tocarcinogenesis: from infection to cancer. Liver Int. 28, 175-188.
183. Tang, Q., Henriksen, K. J., Bi, M., Fin-ger, E. B., Szot, G., Ye, J., Mas-teller, E. L., McDevitt, H., Bony-hadi, M., and Bluestone, J. A. (2004). In vitro-expanded antigen-specific regulatory T cells suppress autoim-mune diabetes. J. Exp. Med. 199, 1455-1465.
184. Tesniere, A., Apetoh, L., Ghiringhelli, F., Joza, N., Panaretakis, T., Kepp, O., Schlemmer, F., Zitvogel, L., and Kroemer, G. (2008). Immunogenic cancer cell death: a key-lock par-adigm. Curr. Opin. Immunol. 20, 504-511.
185. Tiegs, S. L., Russell, D. M., and Nemazee, D. (1993). Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177, 1009-1020.
186. Tonegawa, S. (1983). Somatic genera-tion of antibody diversity. Nature 302, 575-581.
187. Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J., and Ploegh, H. L. (2000). Viral subversion of the immune system. Annu. Rev. Immunol. 18, 861-926.
188. Tsuji, M., Komatsu, N., Kawamoto, S., Suzuki, K., Kanagawa, O., Honjo, T., Hori, S., and Fagarasan, S. (2009). Preferential generation of follicular B helper T cells from Foxp3+ Tcells in gut Peyers patches. Science 323, 1488-1492.
189. Tuovinen, H., Salminen, J. T., and Arstila, T. P. (2006). Most human thymic and peripheral-blood CD4+ CD25+ regulatory T cells express 2T-cellreceptors. Blood 108, 4063-4070.
190. van der Aar, A. M., Sylva-Steenland, R. M., Bos, J. D., Kapsenberg, M. L., de Jong, E. C., and Teunissen, M. B. (2007). Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J. Immunol. 178, 1986-1990.
191. Viglianti, G. A., Lau, C. M., Han-ley, T. M., Miko, B. A., Shlomchik, M. J., and Marshak-Rothstein, A. (2003). Activation of autoreactive B cells by CpG dsDNA. Immunity 19, 837-847.
192. Viglietta, V., Baecher-Allan, C., Weiner, H. L., and Hafler, D. A. (2004). Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971-979.
193. Vignali, D.A., Collison, L.W., and Workman, C. J. (2008). How regulatory T cells work. Nat. Rev. Immunol. 8, 523-532.
194. von Boehmer, H. (2005). Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6, 338-344.
195. von Herrath, M. G., and Harrison, L. C. (2003). Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. 3, 223-232.
196. Walker, L. S., and Abbas, A. K. (2002). The enemy within: keeping self-reactive T cells at bay in the periph-ery. Nat. Rev. Immunol. 2, 11-19.
197. Ward, S. M., Fox, B. C., Brown, P. J., Wor-thington, J., Fox, S. B., Chapman, R. W., Fleming, K. A., Banham, A. H., and Klenerman, P. (2007). Quantifi-cationandlocalisationof FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J. Hepatol. 47, 316-324.
198. Watanabe, N., Wang, Y. H., Lee, H. K., Ito, T., Cao, W., and Liu, Y. J. (2005). Hassalls corpuscles instruct den-dritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 436, 1181-1185.
199. Wayne, J., Suh, H., Misulovin, Z., Sokol, K. A., Inaba, K., and Nussenzweig, M. C. (1994). A regulatory role for recombinase activating genes, RAG-1 and RAG-2, in T cell development. Immunity 1, 95-107.
200. West, K. L., Singha, N. C., De Ioannes, P., Lacomis, L., Erdjument-Bromage, H., Tempst, P., and Cortes, P. (2005). A direct interaction between the RAG2 C terminus and the core histones is required for efficient V(D)J recombination. Immunity 23, 203-212.
201. West, M.A., Wallin, R. P., Matthews, S. P., Svensson, H. G., Zaru, R., Ljunggren, H. G., Prescott, A. R., and Watts, C. (2004). Enhanced dendritic cell anti-gen capture via toll-like receptor-induced actin remodeling. Science 305, 1153-1157.
202. Winau, F., Weber, S., Sad, S., de Diego, J., Hoops, S. L., Breiden, B., Sandhoff, K., Brinkmann, V., Kaufmann, S. H., and Schaible, U. E. (2006). Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immu-nity 24, 105-117.
203. Wykes, M., Pombo, A., Jenkins, C., and MacPherson, G. G. (1998). Den-dritic cells interact directly with naive B lymphocytes to transfer anti-gen and initiate class switching in a primary T-dependent response. J. Immunol. 161, 1313-1319.
204. Yamazaki, S., Inaba, K., Tarbell, K. V., and Steinman, R. M. (2006). Den-dritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol. Rev. 212, 314-329.
205. Yoshikai, Y., Anatoniou, D., Clark, S. P., Yanagi, Y., Sangster, R., Van den Elsen, P., Terhorst, C., and Mak, T. W. (1984). Sequence and expression of transcripts of the human T-cell receptor beta-chain genes. Nature 312, 521-524.
206. Zarember, K. A., and Godowski, P. J. (2002). Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their prod-ucts, and cytokines. J. Immunol. 168, 554-561.
207. Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S., and Flavell, R. A. (2008). Innate and adaptive interleukin-22 protects mice from inflamma-tory bowel disease. Immunity 29, 947-957.
208. Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R., Modrusan, Z., Ghilardi, N., de Sauvage, F. J., and Ouyang, W. (2008). Interleukin-22 mediates early host defense against attach-ing and effacing bacterial pathogens. Nat. Med. 14, 282-289.
209. Zhou, G., and Levitsky, H. I. (2007). Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance. J. Immunol. 178, 2155-2162.
210. Zhou, X., Bailey-Bucktrout, S., Jeker, L. T., and Bluestone, J. A. (2009a). Plas-ticity of CD4(+) FoxP3(+) T cells. Curr. Opin. Immunol. 21, 281-285.
211. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martinez-Llordella, M., Ashby, M., Nakayama, M., Rosenthal, W., and Bluestone, J. A. (2009b). Instability of the tran-scription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007.
212. Zhu, M., Chin, R. K., Christiansen, P. A., Lo, J. C., Liu, X., Ware, C., Siebenlist, U., and Fu, Y. X. (2006). NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway. J. Clin. Invest. 116, 2964-2971.
213. Ziegler, S. F. (2006). FOXP3: of mice and men. Annu. Rev. Immunol. 24, 209-226.
214. Zinkernagel, R. M. (1996). Immunol-ogy taught by viruses. Science 271, 173-178.
215. Zinkernagel, R. M., Planz, O., Ehl, S., Battegay, M., Odermatt, B., Klener-man, P., and Hengartner, H. (1999). General and specific immunosup-pression caused by antiviral T-cell responses. Immunol. Rev. 168, 305-315.
216. Zou, W. (2006). Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6, 295-307.